Structures by: Degtyarenko A. S.
Total: 29
Copper(I) Tetrafluoroborate 4:5 complex with 1,4-bi(pyridazin-4-yl)benzene, solvate with 4 Chloroform
C74H54B4Cl12Cu4F16N20
New Journal of Chemistry (2008) 32, 11 1910
a=12.5703(9)Å b=13.7895(13)Å c=14.1629(12)Å
α=94.203(11)° β=93.205(11)° γ=107.835(10)°
Copper(I) Dithionate bis(Acetonitrile) complex with 1,4-bi(pyridazin-4-yl)benzene
C18H16Cu2N6O6S2
New Journal of Chemistry (2008) 32, 11 1910
a=9.3471(6)Å b=18.9283(11)Å c=12.4791(9)Å
α=90.00° β=101.718(8)° γ=90.00°
Silver(I) nitrate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Chloroform solvate
C15H11AgCl3N5O3
New Journal of Chemistry (2008) 32, 11 1910
a=8.3964(2)Å b=9.5399(2)Å c=12.4383(3)Å
α=80.0473(10)° β=82.901(2)° γ=64.9520(11)°
Silver(I) Pentafluoropropionate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene
C17H10AgF5N4O2
New Journal of Chemistry (2008) 32, 11 1910
a=5.5566(7)Å b=10.5875(13)Å c=15.419(2)Å
α=72.987(10)° β=84.721(11)° γ=82.058(11)°
Silver(I) Trifluoroacetate 4:3 complex with 1,4-bi(pyridazin-4-yl)benzene, Acetonitrile solvate
C52H33Ag4F12N13O8
New Journal of Chemistry (2008) 32, 11 1910
a=10.9059(10)Å b=11.1531(11)Å c=13.8012(13)Å
α=92.620(11)° β=108.916(11)° γ=117.522(10)°
Silver(I) Methanesulfonate 4:3 complex with 1,4-bi(pyridazin-4-yl)benzene, solvate with 2 Chloroform
C48H44Ag4Cl6N12O12S4
New Journal of Chemistry (2008) 32, 11 1910
a=19.3101(19)Å b=17.3714(15)Å c=18.1903(15)Å
α=90.00° β=99.346(5)° γ=90.00°
Silver(I) Benzoate 2:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Hydrate
C28H24Ag2N4O6
New Journal of Chemistry (2008) 32, 11 1910
a=7.2863(3)Å b=14.3867(6)Å c=12.2774(5)Å
α=90.00° β=90.945(3)° γ=90.00°
Silver(I) Isophthalate 1:1 complex with 1,4-bi(pyridazin-4-yl)benzene, Hydrate
C66H62Ag6N12O22
New Journal of Chemistry (2008) 32, 11 1910
a=9.4238(6)Å b=14.2038(12)Å c=14.2032(10)Å
α=104.457(8)° β=98.140(8)° γ=108.924(9)°
Μ-Hexafluorosilicato-tetrakis[μ-1,3-bis(pyridazin-4-yl)benzene- κ^2^N^2^:N^2^]-dimethanol-dicopper(II) hexafluorosilicate, solvate with 3 methanol
C58H48Cu2F6N16O2Si,F6Si,3(CH4O)
Chem.Commun. (2013) 49, 9018
a=17.1490(3)Å b=17.1490(3)Å c=20.7268(9)Å
α=90.00° β=90.00° γ=90.00°
Μ-[Hexafluorosilicato/Hexafluorogermanato 0.89:0.11]- tetrakis[μ-1,3-bis(pyridazin-4-yl)benzene- κ^2^N^2^:N^2^]-dimethanol-dicopper(II) Hexafluorosilicate/Hexafluorogermanate 0.38:0.62, solvate with 3 methanol
C58H48Cu2F6Ge0.11N16O2Si0.89,F6Ge0.62Si0.38,3(CH4O)
Chem.Commun. (2013) 49, 9018
a=17.2531(3)Å b=17.2531(3)Å c=20.5377(10)Å
α=90.00° β=90.00° γ=90.00°
Μ-[Hexafluorosilicato-tetrakis[μ-1,3-bis(pyridazin-4-yl)benzene- κ^2^N^2^:N^2^]-dimethanol-dicopper(II) Hexafluorosilicate/Hexafluorostannate(IV) 0.21:0.79, solvate with 3 methanol
C58H48Cu2F6N16O2Si,F6Si0.21Sn0.79,3(CH4O)
Chem.Commun. (2013) 49, 9018
a=17.3756(4)Å b=17.3756(4)Å c=20.5964(9)Å
α=90.00° β=90.00° γ=90.00°
Μ-Hexafluorosilicato-tetrakis[μ-1,3-bis(pyridazin-4-yl)benzene- κ^2^N^2^:N^2^]-diaquadicopper(II) bis-hexafluorophosphate, solvate with 4 chloroform
C56H44Cu2F6N16O2Si,2(F6P),4(CHCl3)
Chem.Commun. (2013) 49, 9018
a=12.6120(9)Å b=12.6185(7)Å c=25.342(2)Å
α=90.00° β=99.262(9)° γ=90.00°
Μ-[Hexafluorosilicato/Hexafluorogermanate 0.93:0.07]- tetrakis[μ-1,3-bis(pyridazin-4-yl)benzene- κ^2^N^2^:N^2^]-dimethanol-dicopper(II) Hexafluorosilicate/Hexafluorogermanate 0.67:0.33, solvate with 3 methanol
C58H48Cu2F6Ge0.07N16O2Si0.93,F6Ge0.33Si0.67,3(CH4O)
Chem.Commun. (2013) 49, 9018
a=17.1776(8)Å b=17.1776(8)Å c=20.715(2)Å
α=90.00° β=90.00° γ=90.00°
Μ-Hexafluorosilicato-tetrakis[μ-1,3-bis(pyridazin-4-yl)benzene- κ^2^N^2^:N^2^]-dimethanol-dicopper(II) Hexafluorosilicate/Hexafluorostannate(IV) 0.50:0.50, solvate with 3 methanol
C58H48Cu2F6N16O2Si,F6Si0.50Sn0.50,3(CH4O)
Chem.Commun. (2013) 49, 9018
a=17.2903(3)Å b=17.2903(3)Å c=20.5440(10)Å
α=90.00° β=90.00° γ=90.00°
Μ-Hexafluorosilicato-tetrakis[μ-1,3-bis(pyridazin-4-yl)benzene- κ^2^N^2^:N^2^]-aqua-methanoldicopper(II) bis-perchlorate, solvate with 5.5 chloroform
2(C57H46Cu2F6N16O2Si),4(ClO4),11(CHCl3)
Chem.Commun. (2013) 49, 9018
a=12.8708(6)Å b=12.5785(5)Å c=50.263(2)Å
α=90.00° β=93.272(3)° γ=90.00°
Poly[bis-[μ~3~-[1,3-bis(pyridazin-4-yl)adamantane-κ^4^N1:N2:N3)]]- bis[μ~3~-(1,3,5-adamantanetricarboxylato)]-di(μ~3~-hydroxido)- diaquatetracopper(II)] monohydrate
C62H76Cu4N8O18,H2O
Dalton transactions (Cambridge, England : 2003) (2014) 43, 22 8530-8542
a=11.1208(9)Å b=11.5078(10)Å c=13.8841(13)Å
α=83.981(6)° β=67.507(6)° γ=62.065(5)°
Poly[bis-[μ~3~-[1,3-bis(pyridazin-4-yl)adamantane-κ^4^N1:N2:N3)]]- tris[μ~2~-(2,5-thiophenedicarboxylato)]-di(μ~3~-hydroxido)- diaquatetracopper(II)] heptahydrate
C54H52Cu4N8O16S3,7(H2O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 22 8530-8542
a=13.3933(4)Å b=9.9035(3)Å c=23.7661(8)Å
α=90.00° β=98.036(2)° γ=90.00°
Poly[bis-[μ~4~-[1,3-bis(pyridazin-4-yl)adamantane-κ^4^N1:N2:N3:N4)]]- tetrakis-[μ~2~-(1,3-benzenedicarboxylato)]-di(μ~2~-hydroxido)- diaquapentacopper(II)] pentahydrate
C68H62Cu5N8O20,5(H2O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 22 8530-8542
a=10.0517(7)Å b=18.4855(9)Å c=19.1143(13)Å
α=90.00° β=104.721(5)° γ=90.00°
Poly[bis-[μ~4~-[1,3-bis(pyridazin-4-yl)adamantane-κ^4^N1:N2:N3:N4)]]- tetrakis-[μ~2~-(1,3-benzenedicarboxylato)]-di(μ~2~-hydroxido)- diaquapentacopper(II)] pentahydrate
C68H62Cu5N8O20,5(H2O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 22 8530-8542
a=10.0322(6)Å b=18.4439(9)Å c=19.0354(12)Å
α=90.00° β=104.897(5)° γ=90.00°
1,3-Diethynyladamantane
C14H16
Acta Crystallographica Section E (2020) 76, 6 807-810
a=11.3214(9)Å b=6.7426(6)Å c=14.9478(12)Å
α=90° β=107.234(9)° γ=90°
4,4'-(<i>p</i>-phenylene)bipyridazine
C14H10N4
Acta Crystallographica Section C (2008) 64, 7 m254-m258
a=6.3588(7)Å b=6.9307(9)Å c=7.0681(10)Å
α=110.282(3)° β=90.823(3)° γ=106.585(2)°
Catena-poly[[dibromidocopper(II)]-μ~2~-4,4-(<i>p</i>-phenylene)bipyridazine- κ^2^N^2^:N^2'^]
C14H10Br2CuN4
Acta Crystallographica Section C (2008) 64, 7 m254-m258
a=4.1377(2)Å b=12.5407(7)Å c=13.5301(8)Å
α=90.00° β=93.786(4)° γ=90.00°
Catena-poly[[[tetrakis(μ-acetato-κ^2^<i>O</i>:<i>O</i>)dicopper(II)]- μ~2~-4,4'-(<i>p</i>-phenylene)bipyridazine-κ^2^N^1^:N^1'^] chloroform disolvate]
C22H22Cu2N4O8,2(CHCl3)
Acta Crystallographica Section C (2008) 64, 7 m254-m258
a=7.6349(8)Å b=8.0203(8)Å c=13.9312(10)Å
α=104.601(2)° β=103.993(2)° γ=90.123(3)°
Diaquatetrakis[1,4-bis(pyridazin-4-yl)benzene-κ<i>N</i>^2^]cadmium(II) hexaiodidodicadmate(II)
C56H44CdN16O22,Cd2I62
Acta Crystallographica Section C (2013) 69, 3 219-224
a=8.0710(3)Å b=13.0867(5)Å c=15.2422(7)Å
α=81.885(2)° β=81.742(3)° γ=79.870(2)°
Poly[[μ-1,4-bis(pyridazin-4-yl)benzene-κ^2^<i>N</i>^2^:<i>N</i>^2^]bis(μ-thiocyanato-κ^2^<i>N</i>:<i>S</i>)cadmium(II)]
C16H10CdN6S2
Acta Crystallographica Section C (2013) 69, 3 219-224
a=5.9018(6)Å b=7.6619(9)Å c=9.2433(10)Å
α=88.980(12)° β=75.434(11)° γ=87.049(12)°
Poly[di-μ-chlorido-μ~4~-[1,4-bis(pyridazin-4-yl)benzene- -1:2:3:4κ^4^<i>N</i>^1^:<i>N</i>^2^:<i>N</i>^1^:<i>N</i>^2'^]dicopper(I)]
C14H10Cl2Cu2N4
Acta Crystallographica Section C (2014) 70, 2 173-177
a=7.0696(8)Å b=17.2872(16)Å c=6.6046(7)Å
α=90.00° β=115.198(10)° γ=90.00°
Poly[di-μ-bromido-μ~4~-[1,4-bis(pyridazin-4-yl)benzene- -1:2:3:4κ^4^<i>N</i>^1^:<i>N</i>^2^:<i>N</i>^1^:<i>N</i>^2'^]dicopper(I)]
C14H10Br2Cu2N4
Acta Crystallographica Section C (2014) 70, 2 173-177
a=7.1998(6)Å b=17.7305(13)Å c=6.7135(6)Å
α=90.00° β=115.668(9)° γ=90.00°
Poly[μ~3~-[1,3-bis(pyridazin-4-yl)adamantane-κ^4^N1:N2:N3)]-μ~4~- (1,3,5-benzenetricarboxylato)-μ~2~-hydroxido-aquadicopper(II)]
C27H26Cu2N4O8
Dalton transactions (Cambridge, England : 2003) (2014) 43, 22 8530-8542
a=24.8536(18)Å b=10.8716(7)Å c=18.6837(14)Å
α=90.00° β=101.581(8)° γ=90.00°
Poly[bis-[μ~4~-[1,3-bis(pyridazin-4-yl)adamantane-κ^4^N1:N2:N3:N4)]]- tetrakis-[μ~2~-(5-hydroxy-1,3-benzenedicarboxylato)]-di(μ~2~-hydroxido)- diaquapentacopper(II)] hexahydrate
C68H62Cu5N8O24,6(H2O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 22 8530-8542
a=10.0552(5)Å b=18.7840(8)Å c=19.1757(9)Å
α=90.00° β=104.829(2)° γ=90.00°